Literature DB >> 19324084

Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.

Leonidas J Leontiadis1, Maria P Papakonstantinou, Zafiroula Georgoussi.   

Abstract

In vitro studies have shown that the Regulator of G protein Signaling 4 (RGS4) interacts with the C-termini of mu- and delta-opioid receptors (mu-OR, delta-OR) (Georgoussi et al., 2006, Cell. Signal.18, 771-782). Herein we demonstrate that RGS4 associates with these receptors in living cells and forms selective complexes with Gi/Go proteins in a receptor dependent manner. This interaction occurs within the predicted fourth intracellular loop of mu, delta-ORs as part of a signaling complex consisting of the opioid receptor, activated Galpha and RGS4. RGS4 is recruited to the plasma membrane upon opioid receptor stimulation. Expression of RGS4 in HEK293 cells attenuated agonist-mediated extracellular signal regulated kinase (ERK1,2) phosphorylation for both receptors and accelerated agonist-induced internalization of the delta-OR. RGS4 lacking its N-terminal domain failed to interact with both opioid receptors and to modulate opioid receptor signaling. Our findings demonstrate that RGS4 plays a key role in G protein coupling selectivity and signaling of the mu- and delta-OmicronRs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19324084     DOI: 10.1016/j.cellsig.2009.03.013

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  21 in total

Review 1.  A finer tuning of G-protein signaling through regulated control of RGS proteins.

Authors:  Jacob Kach; Nan Sethakorn; Nickolai O Dulin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

Review 2.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

3.  Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.

Authors:  Qin Wang; John R Traynor
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 4.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 5.  μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology.

Authors:  John Traynor
Journal:  Drug Alcohol Depend       Date:  2011-11-29       Impact factor: 4.492

6.  Regulators of G-Protein Signaling (RGS) Proteins Promote Receptor Coupling to G-Protein-Coupled Inwardly Rectifying Potassium (GIRK) Channels.

Authors:  Kylie B McPherson; Emily R Leff; Ming-Hua Li; Claire Meurice; Sherrica Tai; John R Traynor; Susan L Ingram
Journal:  J Neurosci       Date:  2018-08-27       Impact factor: 6.167

7.  In vivo techniques to investigate the internalization profile of opioid receptors.

Authors:  Amynah A Pradhan; Vivianne L Tawfik; Alycia F Tipton; Grégory Scherrer
Journal:  Methods Mol Biol       Date:  2015

8.  RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.

Authors:  Deborah J Luessen; Tyler P Hinshaw; Haiguo Sun; Allyn C Howlett; Glen Marrs; Brian A McCool; Rong Chen
Journal:  Neuropharmacology       Date:  2016-08-12       Impact factor: 5.250

9.  The role of regulator of G protein signaling 4 in delta-opioid receptor-mediated behaviors.

Authors:  Isaac J Dripps; Qin Wang; Richard R Neubig; Kenner C Rice; John R Traynor; Emily M Jutkiewicz
Journal:  Psychopharmacology (Berl)       Date:  2016-09-13       Impact factor: 4.530

10.  Expression and membrane topology of Anopheles gambiae odorant receptors in lepidopteran insect cells.

Authors:  Panagiota Tsitoura; Evi Andronopoulou; Daniela Tsikou; Adamantia Agalou; Maria P Papakonstantinou; Georgia A Kotzia; Vassiliki Labropoulou; Luc Swevers; Zafiroula Georgoussi; Kostas Iatrou
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.